Code of Conduct of Fair Disclosure
In compliance with the requirements of the SEBI (Prohibition of Insider Trading) Regulations, 2015 ("the Regulations") the Pfizer Ltd has informed BSE as follows;1. Pursuant to the requirements of Regulation 8(2) of the Regulations, the Company has formulated the "Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information".... Change in Chief Financial Officer
Pfizer Ltd has informed BSE that Mr. S. Sridhar, the Chief Financial Officer of the Company, will be moving to a new role as Business Unit Head effective close of business on May 12, 2015, consequently, Mr. S. Sridhar will cease to be the Chief Financial Officer of the Company effective the said date.Mr. Ravi Prakash Bhagavathula has been appointed as the Chief Financial Officer of the Company effective May 13, 2015. Updates
Pfizer Ltd has informed BSE that :"The Company hereby wishes to notify that a matter of conciliation between the Workers Union and Management of its manufacturing facility at Goa is being heard at the State Labour Commissioner's office. This follows a charter of demands submitted by the Union. The Management hopes to resolve the matter expeditiously. There is a temporary impact on production for which the Company is putting into place contingency measures." Pfizer Falls on Weak Fourth Quarter Numbers
Pfizer's net profit fell 24 per cent to Rs 42.7 crore from Rs 56 crore during the same period last year. Results Press Release
Pfizer Ltd has submitted to BSE a copy of Results Press Release for the period ended March 31, 2015. Board recommends Dividend
Pfizer Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 05, 2015, inter alia, has recommended a dividend of Rs. 12.50/- per Equity share of Rs. 10/- each (125%) for the financial year ended March 31, 2015. The said dividend, if declared at the ensuing Annual General Meeting of the Company, shall be paid on July 28, 2015. Financial Results & Auditors Report for March 31, 2015 (Standalone) (Audited)
Pfizer Ltd has informed BSE about the Standalone Financial Results & a copy of the Auditors Report for the period ended March 31, 2015. Board to consider Dividend
Pfizer Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 05, 2015, inter alia, to consider and take on record the Audited Financial Results of the Company for the quarter January 01, 2015 to March 31, 2015 and for the financial year ended March 31, 2015 & will also consider recommendation of dividend, if any, for the financial year ended March 31, 2015.... Shareholding Pattern For March 31, 2015
Pfizer Ltd has informed BSE about the Shareholding Pattern as on March 31, 2015.